ACCESSION: MSBNK-SMB_Measured-HSA007R0265000
RECORD_TITLE: Alpha-N-Phenylacetyl-glutamine; LC-ESI-QTOF; MS2; POSITIVE; Generated from DDA dataset; Annotation confidence level 3
DATE: 2025.09.27
AUTHORS: Ryosuke Hayasaka, Akiyoshi Hirayama (Keio Univ.), and Fumio Matsuda (Univ. Osaka)
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
PROJECT: Shin-MassBank project supported by JST
COMMENT: Annotation confidence level 3. The metabolite structure was manually curated by the Shin-MassBank project. This metabolite is found from more than five datasets with confidence level 3
COMMENT: The metabolite structure was automatically characterized by the Shin-MassBank project (see COMMENT: CONFIDENCE). One of the possible structures is shown. The record should be used with caution.
COMMENT: This is an averaged mass spectra data created by averaging 137 product ion spectra among 60 DDA data files in the dataset described below.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS417
COMMENT: DATASET_TITLE Customized Consensus Spectral Library Building for Untargeted Quantitative Metabolomics Analysis with Data Independent Acquisition Mass Spectrometry and MetaboDIA Workflow
COMMENT: DATASET_AUTHORS Zhou Lei, Hyungwon Choi
COMMENT: PRECURSOR_IN_MS1 mz 265.117579; int 999.000; delta(ppm) -5.514994
COMMENT: PROPOSED_MF SevenGoldenRules 0.034; C13H16N2O4; [M+H]+; delta(ppm) 0.034077; Ranking 1;
COMMENT: PROPOSED_MF MS-FINDER 4.303; C13H16N2O4; [M+H]+; delta(ppm) 0.032268; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS5_Sirius 44.372; C13H16N2O4; [M+H]+; delta(ppm) 0.032268; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C13H16N2O4; [M+H]+; delta(ppm) 0.032268; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS6_Sirius 69.514; C13H16N2O4; [M+H]+; delta(ppm) 0.032268; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C13H16N2O4; [M+H]+; delta(ppm) 0.032268; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 4.000; JFLIEFSWGNOPJJ-JTQLQIEISA-N; C13H16N2O4; PHENYLACETYL-GLUTAMINE; Ranking 1;
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.285; JFLIEFSWGNOPJJ-JTQLQIEISA-N; [M+H]+; NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(O)=O; Ranking 2;
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.033; JFLIEFSWGNOPJJ-JTQLQIEISA-N; [M+H]+; Alpha-N-Phenylacetyl-L-glutamine; Ranking 1;
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JFLIEFSWGNOPJJ-JTQLQIEISA-N; [M+H]+; Alpha-N-Phenylacetyl-L-glutamine; Ranking 1;
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; JFLIEFSWGNOPJJ-JTQLQIEISA-N; [M+H]+; (2S)-5-amino-5-oxo-2-[(2-phenylacetyl)amino]pentanoic acid; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -1.554; JFLIEFSWGNOPJJ; [M+H]+; PA-L-Glutamine; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.999; JFLIEFSWGNOPJJ; [M+H]+; PA-L-Glutamine; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -15.341; JFLIEFSWGNOPJJ; [M+H]+; Phenylacetylglutamine; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.998; JFLIEFSWGNOPJJ; [M+H]+; Phenylacetylglutamine; Ranking 1;
COMMENT: CONFIDENCE Tentative candidate (Level 3); Proposed by SIRIUS6_Confidence (FDR < 0.1); Similarity by SIMILARITY:GNPS (Dot product > 0.7, 4 spectra); Supported by CFM-ID:MsfinderDB (Ranking 2), MS-FINDER:MsfinderDB (Ranking 1), MetFrag:MsfinderDB (Ranking 1), MetFrag:PubchemLite (Ranking 1); Biological context by HMDB (HMDB0006344)
CH$NAME: Alpha-N-Phenylacetyl-glutamine
CH$NAME: Phenylacetylglutamine
CH$NAME: 5-amino-5-keto-2-[(2-phenylacetyl)amino]valeric acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C13H16N2O4
CH$EXACT_MASS: 264.111007
CH$SMILES: C1=CC=C(C=C1)CC(=O)NC(CCC(=O)N)C(=O)O
CH$IUPAC: InChI=1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)
CH$LINK: HMDB HMDB0006344
CH$LINK: INCHIKEY JFLIEFSWGNOPJJ-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:306137
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: TripleTOF 5600+, AB Sciex
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 20 to 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 10.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC HSS T3 (3 Âµm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was 2% B from 0 to 1.5 min, 20% B at 7.5 min, 50% B at 12 min, 95% B from 16 to 18 min, and 2% B at 19 to 25 min
AC$CHROMATOGRAPHY: FLOW_RATE 0.35 ml/mi
AC$CHROMATOGRAPHY: RETENTION_TIME 6.652
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 265.118292
MS$DATA_PROCESSING: COMMENT Product ions not positively corelated with the precursor ion were removed (rank order correlation, alpha = 0.01).
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001l-9300000000-eeeb688d57f42f3b4826
PK$ANNOTATION: m/z int mzPAF cor n
  83.060397 142 f{C4H7N2}/0.27ppm,p-C9H10O4 0.8981 127
  84.044536 999 f{C4H6N1O1}/1.73ppm,p-C9H11N1O3 0.8980 136
  91.054590 700 f{C7H7}/3.99ppm,p-C6H10N2O4 0.9127 112
  101.070916 64 f{C4H9N2O1}/-0.23ppm,p-C9H8O3 0.9004 122
  129.065937 164 f{C5H9N2O2}/0.65ppm,p-C8H8O2 0.9286 129
  136.075906 250 f{C8H10N1O1}/1.59ppm,p-C5H7N1O3 0.9070 134
  147.076317 147 f{C5H11N2O3}/-0.69ppm,p-C8H6O1 0.9045 128
  219.112885 13 f{C12H15N2O2}/0.37ppm,p-C1H2O2 0.8492 105
  247.107525 20 f{C13H15N2O3}/-0.78ppm,p-H2O1 0.8681 112
  248.091010 26 f{C13H14N1O4}/-2.92ppm,p-H3N1 0.8846 119
  265.118268 31 f{C13H17N2O4}/-0.06ppm,p 1.0000 125
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  83.060397 142.00 142
  84.044536 999.00 999
  91.054590 700.00 700
  101.070916 64.00 64
  129.065937 164.00 164
  136.075906 250.00 250
  147.076317 147.00 147
  219.112885 13.00 13
  247.107525 20.00 20
  248.091010 26.00 26
  265.118268 31.00 31
//
